Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M413Revenue $M0.2Net Margin (%)-23,292.7Z-Score12.9
Enterprise Value $M285EPS $-1.3Operating Margin %-23,558.1F-Score4
P/E(ttm))0Cash Flow Per Share $-1.1Pre-tax Margin (%)-23,303.3Higher ROA y-yY
Price/Book2.810-y EBITDA Growth Rate %-15.3Quick Ratio11.5Cash flow > EarningsY
Price/Sales05-y EBITDA Growth Rate %-15.7Current Ratio11.5Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-42.2Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)-45.6Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M54.8ROI % (ttm)-93.0Gross Margin Increase y-yN

Gurus Latest Trades with ARWR

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ARWRGeorge Soros 2014-06-30 Sold Out -0.01%$9.79 - $18.28
($13.09)
$ 7.53-42%Sold Out0
ARWRGeorge Soros 2014-03-31 Buy 0.01%$9.92 - $26.57
($17.36)
$ 7.53-57%New holding, 44200 sh.44,200
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ARWR is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


ARWR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Lewis David L.Chief Scientific Officer 2015-01-05Sell15,000$8.01-3.37view
Anzalone Christopher RichardPresident and CEO 2014-10-15Buy16,000$6.3222.47view
Anzalone Christopher RichardPresident and CEO 2014-10-15Buy16,000$6.3222.47view
McKenney CharlesDirector 2014-10-01Sell2,500$14.7-47.35view
Lewis David L.Chief Scientific Officer 2014-09-30Sell15,000$15.02-48.47view
GIVEN DOUGLAS BDirector 2014-09-26Sell2,000$15.24-49.21view
GIVEN DOUGLAS BDirector 2014-08-15Sell5,000$13.9-44.32view
Myszkowski Kenneth AllenCFO 2014-08-15Sell40,000$14.02-44.79view
McKenney CharlesDirector 2014-06-09Sell22,000$14.32-45.95view
Myszkowski Kenneth AllenCFO 2014-02-12Sell16,000$18.77-58.76view

Press Releases about ARWR :

    Quarterly/Annual Reports about ARWR:

    News about ARWR:

    Articles On GuruFocus.com
    Weekly CEO Buys Highlight: NRP, OPK, GAM, KEY, ARWR Oct 20 2014 
    Arrowhead Research Corp. Reports Operating Results (10-Q) Feb 10 2011 
    Weekly CFO Buys Highlight: JAZZ, VRTB, ASTM, ARWR, CGX Sep 04 2010 
    Arrowhead Research Corp. Reports Operating Results (10-Q) May 13 2010 
    Arrowhead Research Corp. Reports Operating Results (10-Q) Feb 11 2010 
    Arrowhead Research Corp. Reports Operating Results (10-K) Dec 22 2009 
    Arrowhead Research Corp. Reports Operating Results (10-Q) Aug 10 2009 
    Arrowhead Reports Third Quarter Fiscal 2009 Financial Results Aug 10 2009 
    Arrowhead Research Corp. Reports Operating Results (10-Q) May 15 2009 
    Arrowhead Research Corp. Reports Operating Results (10-Q) Feb 09 2009 

    More From Other Websites
    Arrowhead Begins Phase 1 Trial of ARC-AAT for Treatment of Liver Disease Associated with Alpha-1... Feb 23 2015
    Arrowhead to Present at 2015 RBC Capital Markets' Global Healthcare Conference Feb 17 2015
    ARROWHEAD RESEARCH CORP Financials Feb 14 2015
    10-Q for Arrowhead Research Corp. Feb 11 2015
    ARWR: Arrowhead Reports Fiscal 1Q15 Financial Results Feb 11 2015
    The News That Should Move Arrowhead Research Today Feb 10 2015
    Arrowhead Research Corp Earnings Call scheduled for 4:30 pm ET today Feb 09 2015
    Arrowhead Research reports 1Q loss Feb 09 2015
    Arrowhead Research reports 1Q loss Feb 09 2015
    ARROWHEAD RESEARCH CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Feb 09 2015
    Arrowhead Reports Fiscal 2015 First Quarter Financial Results Feb 09 2015
    Q1 2015 Arrowhead Research Corp Earnings Release - After Market Close Feb 09 2015
    Arrowhead to Report Fiscal 2015 First Quarter Financial Results Feb 02 2015
    Arrowhead Research Corp (ARWR): Bridger Management Builds 5.5% Passive Stake Jan 26 2015
    Robbins Arroyo LLP Is Investigating the Officers and Directors of Arrowhead Research Corporation... Jan 14 2015
    Arrowhead Research (ARWR) Stock Plummets Today After FDA Partial Clinical Hold Jan 12 2015
    Arrowhead Research Tumbles 20% Following FDA News Jan 12 2015
    FDA places Arrowhead Hep B drug on partial hold, shares plunge Jan 12 2015
    FDA Informs Arrowhead of Partial Clinical Hold for Hepatitis B Drug Jan 12 2015
    FDA asks Arrowhead to cut Hep B drug dosage in mid-stage trial Jan 12 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    Truthtracer@twitter
    ReplyTruthtracer@twitter - 1 year ago
    Correction, carefully read the scientific foundation shared in the 4th quarter report.
    Truthtracer@twitter
    ReplyTruthtracer@twitter - 1 year ago
    Pay attention to the science in the third quarter report. Institutional holdings have increased from 30% to over 70% in 3 months. Reputable, longer term holders...
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK